Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Nektar Therapeutics
Today
Create an eToro account to buy NKTR stock on a secure, user-friendly, multi-asset trading platform.
Buy Nektar Therapeutics
NKTR Price
Nektar Therapeutics NKTR

Nektar Therapeutics News

NKTR Price

Nektar Therapeutics NKTR

$0.910.01(0.81%)(1D)

NKTR Stock Price Chart

-16.19%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Nektar Therapeutics share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Nektar Therapeutics share price today is 0.91, reflecting a 0.81% change over the last 24 hours and -10.2% over the past week. The current market capitalization of NKTR is 167.45M with an average volume in the last three months of 1.76M. The stock has a P/E ratio of -1.08 and a dividend yield of 0%. With the stock’s beta sitting at 1.83
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$167.45M

Day’s Range
i
Shows the high and low prices of the day.
0.84 - 1.04

52W Range
i
Shows the high and low prices of the last year.
0.39 - 1.9

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.76M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-1.08

Revenue
i
The total income generated by this company’s goods and services last year.
$93.14M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$0.91

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.84

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.83

What Is Nektar Therapeutics?
Nektar Therapeutics is a biopharmaceutical company with operations primarily within the US and India. It researches and develops drug candidates for auto-immune diseases and cancer. Founded in 1990, Nektar Therapeutics has headquarters in San Francisco, California. It is listed under the NKTR ticker on the NASDAQ GS stock market. Easily follow the NKTR stock by making it an entry on your eToro watchlist.

How can I buy Nektar Therapeutics stocks?

To purchase Nektar Therapeutics:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Nektar Therapeutics (NKTR) page and place an order to buy Nektar Therapeutics.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Graph
Buy Nektar Therapeutics
Invest in Nektar Therapeutics
Today
Create an eToro account to buy NKTR stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of NKTR is 0.91.
The average price target for Nektar Therapeutics is 0.91. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Nektar Therapeutics based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Nektar Therapeutics is 167.45M
Scroll to top